Wamberg Genomic Advisors Announces The Penn Mutual Life Insurance Company to Provide Cancer Guardian as a Benefit to its Associates
By a
Cancer Guardian is a program that provides guidance, resources and access to leading-edge DNA testing at the time of a cancer diagnosis. Wamberg recently announced enhancements to Cancer Guardian to now include expanded Comprehensive Cancer Support.
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
Triple-s Management Corp. Files SEC Form 8-K, Current Report: (Sept. 6, 2018)
New Findings Reported from Troy University Describe Advances in Risk Management (Heat waves and fatal traffic crashes in the continental United…
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News